Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin

Integrating the monoamine, neurotrophin and cytokine hypotheses of depression — A central role for the serotonin transporter?

(2015) Jana Haase et al.   PHARMACOLOGY & THERAPEUTICS

Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism–smoking interactions differentially predict the odds of major depression and bipolar disorder

(2014) Chiara Cristina Bortolasci et al.   JOURNAL OF AFFECTIVE DISORDERS

AUGMENTATION OF FLUOXETINE WITH LOVASTATIN FOR TREATING MAJOR DEPRESSIVE DISORDER, A RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED-CLINICAL TRIAL

(2013) Ahmad Ghanizadeh et al.   DEPRESSION AND ANXIETY

CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies

(2013) Vyara Valkanova et al.   JOURNAL OF AFFECTIVE DISORDERS

Fluoxetine and citalopram decrease microglial release of glutamate and d-serine to promote cortical neuronal viability following ischemic insult

(2013) K.S. Dhami et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia

(2012) Ross J. Tynan et al.   BRAIN BEHAVIOR AND IMMUNITY

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Subthreshold Hypomanic Symptoms in Progression From Unipolar Major Depression to Bipolar Disorder

(2010) Jess G. Fiedorowicz et al.   AMERICAN JOURNAL OF PSYCHIATRY

Association of high-sensitivity C-reactive protein with de novo major depression

(2010) Julie A. Pasco et al.   BRITISH JOURNAL OF PSYCHIATRY

The Use of Statins After a Cardiac Intervention Is Associated With Reduced Risk of Subsequent Depression

(2010) Lesley Stafford et al.   JOURNAL OF CLINICAL PSYCHIATRY

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders

(2010) Wijnand Laan et al.   JOURNAL OF CLINICAL PSYCHIATRY

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

(2010) M. Berk et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Last Observation Carried Forward Versus Mixed Models in the Analysis of Psychiatric Clinical Trials

(2009) Robert M. Hamer et al.   AMERICAN JOURNAL OF PSYCHIATRY

Mood episodes and mood disorders: patterns of incidence and conversion in the first three decades of life

(2009) Katja Beesdo et al.   BIPOLAR DISORDERS

Minocycline effects on cerebral edema: Relations with inflammatory and oxidative stress markers following traumatic brain injury in mice

(2009) Shadi Homsi et al.   BRAIN RESEARCH

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

(2009) Piotr Gałecki et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

A Preliminary Study of Cytokines in Suicidal and Nonsuicidal Adolescents with Major Depression

(2009) Vilma Gabbay et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

IN VITRO ANTI-OXIDANT AND DNA PROTECTIVE EFFECTS OF THE NOVEL 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR ROSUVASTATIN

(2008) TA Ajith et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats

(2008) Pierre Sicard et al.   FREE RADICAL RESEARCH

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

(2008) Felicity Ng et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis

(2007) Nicole Schupp et al.   ATHEROSCLEROSIS

Pro-inflammatory cytokines and treatment response to escitaloprsam in major depressive disorder

(2007) Triin Eller et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY